In 2024, 4% of U.S. adults were prescribed a GLP-1 therapy — a 363.7% increase from 0.9% in 2019, according to a Fair Health analysis of more than 51 billion commercial claim records.  Fair Health ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity.

Carrying extra pounds on your body can put you at risk of diabetes, high blood pressure, heart disease, and even cancer.

Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to newly released FAIR ...

Erin Davis/Axios VisualsMore than 2% of Americans are taking the blockbuster class of GLP-1 drugs for overweight or obesity, up nearly 600% over six years, according to a report from FAIR Health given ...

Destinee and Dynastiee are identical twins who need to lose weight. Combined they weigh 1,200 pounds and seek help from ...

Obesity specialists say first-generation anti-obesity medications often get a ‘bad wrap,’ but these drugs can be effective ...

Discover a recent study investigating how fibrinogen variants relate to obesity, MASLD, and liver fibrosis severity.

What began as a step toward better health nearly became a deadly decision for Stacey Hillenbrand. After undergoing bariatric surgery outside of the United ...

To be honest, I believe Chris Combs has outgrown his supporting position on 1000-lb Sisters. Based on what I've seen, his journey has been nothing short of inspirational.

Dr. John Woody Major recently completed his 1,000th robotic surgery at Wellstar West Georgia. Major is a board-certified ...

aMedical Department III – Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, 04103, Germany bHelmholtz Institute for Metabolic, Obesity and Vascular Research ...